Amp of Canada Free Essays

Preface Other than on-the-job training, case studies and situations are perhaps the best way to learn project management. Case studies allow the students to apply the knowledge learned in lectures. Case studies require that the students investigate what went right in the case, what went wrong, and what recommendations should be made to prevent these problems from reoccurring in the future. We will write a custom essay sample on Amp of Canada or any similar topic only for you Order Now The use of cases studies is applicable both to undergraduate and graduate level project management courses, as well as to training programs in preparation to pass the exam to become a Certified Project Management Professional (PMP~a)d ministered by the Project Management Institute. Situations are smaller case studies and usually focus on one or two specific points that need to be addressed, whereas case studies focus on a multitude of problems. The table of contents identifies several broad categories for the casesand situations, but keep in mind that the larger case studies, such as Convin Corporation and The Blue Spider Project, could have been listed under several topics. Several of the cases and situations have â€Å"seed† questions provided to assist the reader in the analysis of the case. An instructor’s manual is available from John Wiley Sons, Inc. , to faculty members who adopt the book for classroom use. Almost all of the case studies are factual. In most circumstances, the cases and situations have been taken from the author’s consulting practice. Some educators prefer not to use case studies dated back to the 1970s and 1980s. It would be easy just to change the dates but inappropriate in the eyes of the author. The circumstances surrounding these cases and situations are the same today as they were twenty years ago. Unfortunately we seem to be repeating several of the mistakes made previously. Part 1 PROJECT MANAGEMENT METHODOLOGIES As companies approach some degree of maturity in project management, it becomes readily apparent to all that some sort of standardization approach is necessary for the way that projects are managed. The ideal solution might be to have a singular methodology for all projects, whether they are for new product development, information systems, or client services. Some organizations may find it necessary to maintain more than one methodology, however, such as one methodology for information systems and a second methodology for new product development. The implementation and acceptance of a project management methodology can be difficult if the organization’s culture provides a great deal of resistance toward the change. Strong executive leadership may be necessary such that the barriers to change can be overcome quickly. These barriers can exist at all levels of’ management as well as at the worker level. The changes may require that workers give up their comfort zones and seek out new social groups. Part 2 IMPLEMENTATION OF PROJECT MANAGEMENT The first step in the implementation of project management is to recognize the true benefits that can be achieved from using project management. These benefits can be recognized at all levels of the organization. However, each part of the organization can focus on a different benefit and want the project management methodology to be designed for their particular benefit. Another critical issue is that the entire organization may not end up providing the same level of support for project management. This could delay the final implementation of project management. In addition, there may be some pockets within the organization that are primarily project-driven and will give immediate support to project management, whereas other pockets, which are primarily non-project-driven, may be slow in their acceptance. How to cite Amp of Canada, Papers

Bonds and The Bond Market Essay Example For Students

Bonds and The Bond Market Essay DURATION, SENSITIVITY AND PLA IN BONDSIwould like to help some of you with a general explanation on how to calculatesensitivity and PLA in bonds. Many of you may know these issues, but I preferedto send a general message. Please disregard this CM if this is your case. Themarket factor (what generates the risk) in a bond, is the yield (the interestrate embedded in the investment). This means that the Position Sensitivityshould relate to changes in yields. This sensitivities, then, multiplied by thevolatility of the yields, would give us the PLA associated with the bondpositions (expected portential loss if the yield moves agains us). To calculatethe Position Sensitivity, first of all, you should know the modifiedduration of the bonds that you are holding. Duration is defined as theequivalent tenor in a bond, expressed in terms of a zero coupon bond (a bondthat has only one payment at maturity and it is traded at discount). This meansthat for example, an investor should be completely indiferent to invest in azero coupon bond of 2.25 years than in a 4 years bond (lets say with annualprincipal and interest payment) with also a 2.25 years duration. How tocalculate this duration (also known as Macaulay duration): Lets suppose thisbonds cash flow: ($100 bond with 4 equal annual principal payment and 10%interest rate on outstandings). Lets also assume that we bought at $96 (atdiscount), equivalent to a 12% yield. Coupons Disc at 12% % on price coupontenor (1) * (2) Ppal+ Interest in years (1) (in years)(2) 1 25+10 =35 31.25 33% 1 0. 33 2 25+ 7.5= 32.5 25.91 27% 2 0. 54 3 25+ 5 = 30 21.35 22% 30.66 4 25+ 2.5= 27. 5 17.49 18% 4 0.72 - - 96 100% 2.25 Theduration of this bond is 2. 25 years, even though the final maturity is 4 years,because there are some coupons that are received before the 4 years. As you see,duration is related with the current level of yiels How to calculate themodified duration: Just by dividing the Macaulay duration by (1+the yield in onediscount period). In the example above, the discount period is 1 year (it wasdone on an annual basis, so we should discount the annual yield. However, if thediscount would have been done, for example, in a semi-annual basis, the discountperiod would have been 6 months, and we should divide by the semi-annual yield). Modified duration = macaulay duration divided by (1+yield) Modified duration =2.25 / (1.12) = 2.01 How to calculate Position Sensitivity: PS = Volume ofposition * 0. 01 * modified duration (unit shift = 1%) PS = Volume of position *0.0001 * modified duration (unit shift = 1bp) How to calculate PLA: PLA = PS *yield volatility * square root of days in the defeasance period Note that yieldvolatility should be expressed in terms of 1% if the unit shift is 1% or interms of 1 bp, if the unit shift is 1bp. General examples: 1) Lets assume wehave the bond of the example above ($96.000 position), the unit shift consideredis 1bp, the O/N volatility of the yield is 60 bps and the defeasance period is 4days PS = 96. 000 * 2.01 * 0.0001 = $19.3 (each time the yield changes 1bp, theposition changes $19. 3) PLA = 19.3 * 60 * square root of 4 PLA = 19.3 * 120 =$2316 (if the yield moves 120 bps in the wrong direction, the potential losswould be $2316) 1) Lets assume we have the bond of the example above ($96.000position), the unit shift considered is 1%, the O/N volatility of the yield is60 bps (0. .u904d7ecc221fabf3235b29b8daf485c1 , .u904d7ecc221fabf3235b29b8daf485c1 .postImageUrl , .u904d7ecc221fabf3235b29b8daf485c1 .centered-text-area { min-height: 80px; position: relative; } .u904d7ecc221fabf3235b29b8daf485c1 , .u904d7ecc221fabf3235b29b8daf485c1:hover , .u904d7ecc221fabf3235b29b8daf485c1:visited , .u904d7ecc221fabf3235b29b8daf485c1:active { border:0!important; } .u904d7ecc221fabf3235b29b8daf485c1 .clearfix:after { content: ""; display: table; clear: both; } .u904d7ecc221fabf3235b29b8daf485c1 { display: block; transition: background-color 250ms; webkit-transition: background-color 250ms; width: 100%; opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; background-color: #95A5A6; } .u904d7ecc221fabf3235b29b8daf485c1:active , .u904d7ecc221fabf3235b29b8daf485c1:hover { opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; background-color: #2C3E50; } .u904d7ecc221fabf3235b29b8daf485c1 .centered-text-area { width: 100%; position: relative ; } .u904d7ecc221fabf3235b29b8daf485c1 .ctaText { border-bottom: 0 solid #fff; color: #2980B9; font-size: 16px; font-weight: bold; margin: 0; padding: 0; text-decoration: underline; } .u904d7ecc221fabf3235b29b8daf485c1 .postTitle { color: #FFFFFF; font-size: 16px; font-weight: 600; margin: 0; padding: 0; width: 100%; } .u904d7ecc221fabf3235b29b8daf485c1 .ctaButton { background-color: #7F8C8D!important; color: #2980B9; border: none; border-radius: 3px; box-shadow: none; font-size: 14px; font-weight: bold; line-height: 26px; moz-border-radius: 3px; text-align: center; text-decoration: none; text-shadow: none; width: 80px; min-height: 80px; background: url(https://artscolumbia.org/wp-content/plugins/intelly-related-posts/assets/images/simple-arrow.png)no-repeat; position: absolute; right: 0; top: 0; } .u904d7ecc221fabf3235b29b8daf485c1:hover .ctaButton { background-color: #34495E!important; } .u904d7ecc221fabf3235b29b8daf485c1 .centered-text { display: table; height: 80px; padding-left : 18px; top: 0; } .u904d7ecc221fabf3235b29b8daf485c1 .u904d7ecc221fabf3235b29b8daf485c1-content { display: table-cell; margin: 0; padding: 0; padding-right: 108px; position: relative; vertical-align: middle; width: 100%; } .u904d7ecc221fabf3235b29b8daf485c1:after { content: ""; display: block; clear: both; } READ: Mindwalk: International Relations Essay6%) and the defeasance period is 4 days PS = 96.000 * 2.01 * 0.01 =$1930 (each time the yield changes 1%, the position changes $1930) PLA = 1930 *0. 6 * square root of 4 PLA = 1930 * 1.2 = $2316 (if the yield moves 1,20 % inthe wrong direction, the potential loss would be $2316) As you see, the PLA forboth examples is the same. By changing the unit shift, we only change the way wereport sensitivity, but the risk of the whole transaction (PLA) should be thesame.

Research in International Business and Finance

Question: Discuss about the Research in International Business and Finance. Answer: Introduction: Interest is an indivisible piece of present financial exercises and it is additionally the principle reason of vacillation and obstacles in monetary improvement as a result of loan fee cash is considered as item instead of medium of trade and it makes unequal dissemination of riches inside the general public as centralization of cash stays in few hands henceforth rich ends up noticeably wealthiest and poor ends up noticeably poorer. On the off chance that we characterize loan fee then it is the measure of cash that bank gets or borrower pays in abundance of genuine cash or we can state it cost of capital.(Trinugroho, 2014) Bank Negara Malaysia (BNM) chose to keep the Overnight Policy Rate unaltered at 3.00% at its 23 November money related arrangement meeting, as broadly expected by market examiners. The statutory hold prerequisite (SRR) was likewise left unaltered at 3.50%. (Amin, 2013) The choice to hold the Overnight Policy Rate unaltered recommends that the Central Bank is more stressed over supporting the ringgit than boosting Malaysia's drowsy economy. The ringgit is Asia's most exceedingly terrible performing cash since Trump's astounding triumph in the U.S. presidential racesit has fallen over 5% from that point forward. With respect to ringgit, the Bank expressed in its public statement that it will keep on providing liquidity to guarantee the precise working of the outside trade showcase. Regarding the household economy, Bank Negara considers that private utilization will keep on being the key driver of development, as the administration is relied upon to actualize measures to lift extra cash. In the interim, send out development ought to stay repressed given the dull request from Malaysia's key exchanging accomplices and, generally speaking, money related specialists assess the economy to develop inside desires in 2016, and to proceed on an enduring development way one year from now. (Miyajima, 2014) Bank Negara finished up its official statement by expressing that, "the level of money related accommodativeness is reliable with the arrangement position to guarantee that the household economy proceeds on an unfaltering development way in the midst of stable swelling, upheld by proceeded with sound monetary intermediation in the economy." Meanwhile, the Bank ventures expansion to be at the lower end of the anticipated scope of 2.0%-2.5% and it anticipates that it will remain moderately stable in 2017. (Cevik, 2015) The board of financial investigators we studied during the current month's Consensus Forecast expect the money related approach rate to end this year at 2.90%. Our board anticipates that the approach rate will remain essentially unaltered at 2.89% before the finish of 2017.(Shamsuddin, 2014) The main two dangers the full scale monetary condition and dangers of sharp changes in loan fees are like these Asia Pacific domains. All inclusive, the finish of quantitative facilitating, the uncertain sovereign obligation circumstance and vulnerability about conditions in developing markets, for example, China remains a worry. Then again, the vulnerability on how banks and borrowers could adapt to an ascent in financing costs on the residential front could trigger a flood of terrible advances, particularly in family unit obligations, bringing about higher non-performing advances or debilitated advances proportion. The expansion in family obligation is likewise an outcome of rising property costs on the back of financial jolt measures like the presentation of GST and in addition the climb in the overnight approach rate (OPR). The overview additionally uncovered that Malaysian financiers are more apprehensive about the business' future contrasted with their worldwide partners. Be that as it may, Malaysian brokers are likewise moderately all around arranged to confront these dangers. "Customarily, Malaysian financiers have dependably been mindful about the hazard standpoint of the business, which clarifies the generally abnormal state of tension among Malaysian banks contrasted with different nations all inclusive". "A few elements add to this abnormal state of uneasiness expanded rivalry, increasing expenses of working together and consistence (the 3Cs). Be that as it may, this assumption of reasonability and self-control, together with Bank Negara's support in overseeing and managing the money related market may well help Malaysian investors to feel more arranged to manage the dangers distinguished." (Ismail, 2014) As a key exchanging accomplice of China, Malaysia's exchange parities is at the danger of being affected contrarily by falling ware costs, because of the financial stoppage in China. "Banks are venturing up their endeavors on hazard administration and administration, and putting resources into ability". "These are initial needs in tending to these outside market weights, which are an integral part of dealing with the inexorably complex money related scene, and creating feasible development and upper hand." (Hammoudeh, 2016) Drawing in and holding ability is naturally a key worry among Malaysian financiers, reflecting Asia Pacific needs. Curiously, Asia Pacific is the main locale that saw ability as a main ten issue. For the developing economies, ability is a key focused differentiator, subsequently fabricating a solid ability pipeline remains a diligent test. Other key worries in Malaysia nature of hazard administration and subordinates are likewise firmly connected to the issue of ability. Banks need to ponder "incapable" hazard chiefs who need impact and expert, notwithstanding the issue of losing basic ability to different districts. There is likewise the worry about the tenacious quest for new and fascinating items like subsidiaries. Chance administration groups are relied upon to "get up to speed" with the most recent advancements in the capital market as the dangers related with subsidiary items can be high. (Van Leuvensteijn, 2013) Unmistakably, staying existing conditions is impossible for banks. The test is for banks to consider which pose they wish to embrace to prevail in the commercial center, in connection to the administrative circumstance, the bank's present market position, its desires for the future and its capacities. Fluctuations of Interest Rate Fluctuations in loan fees may adversely affect the matter of our Banks. Our Banks' fundamental wellspring of pay from operations is net premium wage, which is equivalent to the distinction between the premium salary got on enthusiasm bearing resources (normally credits and speculation securities) and the premium cost brought about regarding enthusiasm bearing liabilities (typically stores and borrowings)(Tang, 2015). These rates are profoundly delicate to many components outside our ability to control, including general financial conditions, both local and remote, and the money related and monetary arrangements of different administrative and administrative experts. Our Banks' net premium wage can be influenced fundamentally by changes in market loan costs. Changes in relative loan fees may diminish our Banks' net premium salary as the distinction between premium pay and premium cost diminishes. Thus, our Banks have embraced resource and obligation administration strategies to limit the potential antagonistic impacts of changes in financing costs on net premium pay, fundamentally by adjusting the blend and development of advances, ventures and subsidizing sources. Nonetheless, even with these strategies set up, an adjustment in loan costs can affect our aftereffects of operations or monetary condition. (Ibrahim, 2014) An expansion in financing costs could likewise negatively affect our Banks' consequences of operations by decreasing the capacity of borrowers to reimburse their present advance commitments, which couldn't just outcome in expanded credit defaults, abandonments and discounts, additionally require additionally increments to the Banks' recompenses for advance misfortunes. Increments in financing costs, in specific conditions, may likewise prompt large amounts of advance prepayments, which may likewise adverse effect the net intrigue wage.(Papadamou, 2015) Consequences on Treasury Operations Introduction to loan fee hazard can prompt a decrease in future money streams, make liquidity issues and even debilitate the very presence of an organization. Due to the globalization of the budgetary markets, this has been a developing issue for organizations to manage. As specified some time recently, late outside stuns and new bookkeeping directions put heavier request on organizations. With a specific end goal to decrease these dangers and to keep away from undesirable variances in salary, organizations should hence gauge and oversee them. The issue begins from the traditional hypothesis of Asset-Liability Management (ALM), i.e. the hazard that emerges because of a confuse amongst resources and liabilities of the organization. Loan fee hazard is one of the themes in ALM and emerges because of the befuddle in financing cost levels of benefits and liabilities which prompts distinctive and capricious money streams. (Cerutti, 2014) The treasury office is the focal point of monetary operations inside an organization. Its motivation is to give monetary and treasury benefits inside the organization, and to deal with its property and liquidity, including money related hazard administration. Cases of dangers oversaw by the treasury office are liquidity chance, outside trade chance, financing cost chance, product hazard and credit chance. Little organizations more often than not out-source such administrations to outer banks, while it can be valuable for greater organizations to run its own area of expertise for such administrations. Treasury divisions can be viewed as an interior bank for the organization bunch. In this way, speculations with respect to budgetary organizations can be connected to treasury divisions. A significant contrast between treasury offices and standard banks is that they are not controlled a similar way, and banks are under more noteworthy supervision. (Jomo, 2016) The GDP development rate in all nations plunged, with created nations, for example, the US, Germany, and France enlisting negative development in 2009. At the same time, unemployment rate, which achieved a five year high of 5.9% in the US amid 2008, took off to more than 9.4% by 2009. Also, the US enrolled negative expansion (flattening) of 0.3% in 2009(Tsen Wong, 2013). These were the main considerations constraining the US government to cut loan fees to push monetary development, goad spending, decrease unemployment rate, and keep expansion at a sensible level. (Erge, 2013) Low loan costs demonstrate gainful to moneylenders for a limited ability to focus time, given the higher loaning action. Nonetheless, the store rates are diminished at a much slower rate, as the banks attempt to draw in more contributors, to exploit the high loaning action, subsequently bringing about lower net premium edge. This shrank the net premium edges (NIM) for banks in the US from around 4.0% in 2008 to around 3.2% in 2013. Nations, for example, Saudi Arabia and Qatar that have their monetary forms pegged against the USD are straightforwardly affected by the adjustments in financing costs in light of the fact that these nations have extremely constrained alternatives and need to change loan fees couple with the US to keep up the cash peg. Thusly, the NIM in Saudi Arabia declined from 3.3% in 2008 to around 2.7% in 2013. The adjustments in the US loan costs don't affect the rising economies (monetary standards are not pegged to the USD) specifically, but rather it impacts in a roundabout way through capital markets. As the loan fees in the US and other created economies diminish, financial specialists looking for higher returns move to the developing markets. Besides, the NIM in various nations did not exhibit any immediate connection because of different variables, for example, rivalry among banks, diverse plans of action for banks, and extent of premium pay to the aggregate wage earned by banks.(Malik, 2014) Strategies to safeguard their assets, liabilities, earnings and shareholder value A bank's net premium edge the distinction between the rate that it pays on stores and the rate that it gets on its benefits (credits and securities) is a component of loan fee affectability and the volume and blend of advantages and liabilities. To the degree that a bank gets here and now and loans long haul, it has a confound that it needs to address through rebuilding of advantages and liabilities or utilizing subsidiaries (swaps, swap choices, alternatives and prospects) to fulfill the requirement.(Abdullah, 2015) Conclusion Macroeconomic variables decide the progressions in repo rate, however instabilities in the economy, at a specific point in time has the most noteworthy impact in foreseeing the progressions in repo rate. Besides, loan fee (repo rate) changes positively affect the benefit (net premium edge) of business banks in Malaysia. Thirdly, little business banks really encounter increment in benefit (net premium edge) both completely and with respect to huge banks in times of rising loan fees. This demonstrates there is a positive connection between financing cost and banks show expanding gainfulness with rising loan cost.(Mazlan, 2016) Fourthly, financing cost changes essentially increment the total assets of business banks in Malaysia, however this impact was opposite and not any more critical when estimation was done independently on of all shapes and sizes banks. In any case, macroeconomic variables (swelling, cash supply, and vulnerability) separately took care of don't essentially influenc e the benefit of business banks. Be that as it may, swelling and vulnerability altogether increment the total assets of the little business banks in Malaysia. This implies Malaysian banks (particularly the little ones) could concentrate on estimating and supporting the macroeconomic components that decide financing costs as opposed to the concentrating on loan fees themselves. At last, liquidity proportion has the most noteworthy impact on banks' net premium edge and total assets with respect to the next bank-particular (interior) components References List Abdullah, A., Bakar, M. J. A. (2015). The application of gold price, interest rates and inflation expectations in capital markets.International Journal of Economics and Finance,7(2), 293. Amin, H., Abdul-Rahman, A. R., Abdul-Razak, D. (2013). An integrative approach for understanding Islamic home financing adoption in Malaysia.International Journal of Bank Marketing,31(7), 544-573. Cerutti, E., Claessens, S., Ratnovski, L. (2014).Global liquidity and drivers of cross-border bank flows(No. 14-69). International Monetary Fund. Cevik, S., Charap, J. (2015). The behavior of conventional and Islamic bank deposit returns in Malaysia and Turkey.International Journal of Economics and Financial Issues,5(1), 111. Erge, E. H., Arslan, B. G. (2013). Impact of interest rates on Islamic and conventional banks: the case of Turkey.Applied Economics,45(17), 2381-2388. Hammoudeh, S., Kim, W. J., Sarafrazi, S. (2016). Sources of fluctuations in Islamic, US, EU, and Asia equity markets: the roles of economic uncertainty, interest rates, and stock indexes.Emerging Markets Finance and Trade,52(5), 1195-1209. Ibrahim, M. H., Law, S. H. (2014). House prices and bank credits in Malaysia: An aggregate and disaggregate analysis.Habitat International,42, 111-120. Ismail, S., Azmi, F., Thurasamy, R. (2014). Selection criteria for Islamic home financing in Malaysia.International Journal of Business and Society,15(1), 97. Jomo, K. S. (2016).Growth and structural change in the Malaysian economy. Springer. Malik, M. F., Khan, S., Khan, M. I., Khan, F. (2014). Interest rate and its effect on Banks profitability.Journal of Applied Environmental and Biological Sciences,4, 225-229. Mazlan, N. F., Ahmad, N., Jaafar, N. (2016). Bank Fragility and Its Determinants: Evidence from Malaysian Commercial Banks. InProceedings of the 1st AAGBS International Conference on Business Management 2014 (AiCoBM 2014)(pp. 547-555). Springer Singapore. Miyajima, K., Mohanty, M. S., Yetman, J. (2014). Spillovers of US unconventional monetary policy to Asia: the role of long-term interest rates. Papadamou, S., Sidiropoulos, M., Spyromitros, E. (2015). Central bank transparency and the interest rate channel: Evidence from emerging economies.Economic Modelling,48, 167-174. Shamsuddin, A. (2014). Are Dow Jones Islamic equity indices exposed to interest rate risk?.Economic Modelling,39, 273-281. Tang, T. C., Tan, P. P. (2015). Real interest rate and house prices in Malaysia: An empirical study.Economics Bulletin,35(1), 270-275. Trinugroho, I., Agusman, A., Tarazi, A. (2014). Why have bank interest margins been so high in Indonesia since the 1997/1998 financial crisis?.Research in International Business and Finance,32, 139-158. Tsen Wong, H. (2013). Real exchange rate misalignment and economic growth in Malaysia.Journal of Economic Studies,40(3), 298-313. Van Leuvensteijn, M., Srensen, C. K., Bikker, J. A., Van Rixtel, A. A. (2013). Impact of bank competition on the interest rate pass-through in the euro area.Applied Economics,45(11), 1359-1380.

Building Value Based Healthcare Business Models Essay Example

Building Value Based Healthcare Business Models Essay The task the industries face-?demonstrating value based on a product focus-?is far from simple. For one thing, there are inherent limitations to the value a single drug can bring to the management of complex, chronic diseases, where therapeutic success is determined not only by the molecule but by a combination Of drugs, physician intervention, home assistance, and lifestyle changes. Moreover, providing better health outcomes in exchange for fewer resources means that medications and interventions must be targeted to the right patients. However, personalized medicine has yet to significantly permeate he operating models of the pharmaceutical and medical technology industries. But perhaps most importantly, recent value-based price negotiations have revealed a dramatic lack of trust on both sides of the table. The pharmaceutical industry has often been accused of using its marketing machinery to churn out pills that deliver high margins no matter what value they bring to patients. And the industry perceives healthcare payers restrictions as short-sighted penny-pinching that inhibits access to medicines and curbs innovation. In this climate, agreeing on the definition of value, let lone on the standards of evidence for value, is difficult. And indeed, even as healthcare payers push providers to show evidence of outcome, they continue to steer their spending via strict cost control. As a result, arbitrary price pressures (including forced rebates) are exerted on products in the current portfolio, and it is increasingly difficult to get new products approved for reimbursement. We will write a custom essay sample on Building Value Based Healthcare Business Models specifically for you for only $16.38 $13.9/page Order now We will write a custom essay sample on Building Value Based Healthcare Business Models specifically for you FOR ONLY $16.38 $13.9/page Hire Writer We will write a custom essay sample on Building Value Based Healthcare Business Models specifically for you FOR ONLY $16.38 $13.9/page Hire Writer The outlook may be muddled, but one thing is clear: Players will need to radically adapt. Medical technology companies will struggle to command a price premium for new technology and will need to develop user-friendly, affordable solutions. And pharmaceutical companies, traditionally product- focused organizations, will need to readjust their processes, all the way from development through marketing, to collect and promote evidence of the value their products provide to the healthcare system. Capturing Value with Patient-Centric Solutions Is there an innovative way to deal with the value challenge? Several companies are embracing patient-centric solutions as an alternative business model to the traditional product focus. These models-?exemplified in the United Kingdom by Pfizer Health Solutions, a division that runs integrated are programs for chronic diseases-?aim to increase quality of life and avoid costly hospital treatments by offering prevention, early diagnosis, and remote care to chronically ill patients. The value proposition for healthcare payers is evident: These programs seek to reduce costs and, in theory, can legitimately aspire to be commissioned by a national health service (think the United Kingdom) or reimbursed by health insurance companies (for example, in Germany, the Netherlands, and Switzerland) or local health authorities (think Italy)-?whether on a per-patient or per-time basis, or using a risk-sharing del. Innovative solutions can be driven by technology such as remote monitoring or e-health applications or by medical understanding of certain diseases-?the distinguishing competencies 2 of medical technology and pharmaceutical companies respectively. Philips, for example, launched its Motivate telekinetic remote monitoring program based on its device tech oenology but provides an integrated service. 1 Austereness, on the other hand, teamed up with Singer Health System in the United States to develop an e-health initiative to reduce cardiovascular disease and improve patient care. Additionally, smaller companies and start-ups are developing a Wide range of services. For example, Tallies, an Italian e-health company, provides telekinetic services to national and local payers, and SSL Telekinetic provides services to health insurance companies in Israel and Germany. Where do patient-centric solutions stand? Of course, providing health solutions is not a new idea, and neither is applying IT in health services. In the past decade, there has been no shortage of ideas on how communications technologies could revolutionize the delivery of health services. Certainly, the hype cycle has gone a full round. Similarly, pharmaceutical companies have discussed services as a possibility for adjacent innovation and life-cycle management every now and then. But the expectations voiced a decade ago remain unfulfilled, resulting in widespread skepticism about whether this time is different. But for several reasons, this time is different. For one thing, the product- based pharmaceutical business model has been under more pressure than ever. Ten years back, sovereign healthcare payers still had money, and the sequencing of the human genome promised to make drug innovation easier, quicker, and cheaper. Neither holds true today. And over the years, market players have learned that patient-centric health solutions are not just another application of information and communication technology-?popular thinking in the midst of the dot. Com boom-?but need viable value propositions for the health system. The learning curve has improved, and examples of patient- centric health solutions can be found in many healthcare markets. A look at more than 1 00 services now offered by pharmaceutical and medical technology companies reveals a continuum that ranges from products to stand-alone, value-based services: Product-related services have evolved straight from the products. Examples include patient adherence programs such as Roachs Motivation, Advice, and Proactive (MAP) Support Program for patients prescribed Conical obesity treatment, Chastenesss interactive online program for asthma patients taking Symbiotic, or Innovators Extract support program for multiple sclerosis patients. In medical technology, the Philips Ambient Experience lets patients personalize their exam room with lights, images, and sounds-?for example, replicating an African savanna, a rainy forest, a robots space journey, or an underwater adventure-?while undergoing diagnostic jesting with the companys devices. ; Adjacent services still use the basic product but go beyond it in their value proposition. Rock?s tell-health project in rural Great Britain to support patients with recurring urinary tract infections revolves around the companys Uriss diagnostic device, and Freshness Medical Cares [emailprotected] program in the United States provides comprehensive patient education for Its home dialysis products. All trademarks cited in this paper remain the property of their respective holders and are used only to directly describe the products or services being provided. ; In addition, there are already examples of truly stand-alone, value-based healthcare services, independent of single product use, along the patient pathway. Pfizer online male health clinic provides anonymous, confidential consultation at the users convenience. Wellheads diabetes manager provides a modular service for supporting medication adherence, clinical research trials, and disease management through the Internet and mobile devices. And Philips combines home-based tell-monitoring with an interactive health platform to promote behavioral change for patients with chronic illnesses such as chronic obstructive pulmonary disease (COP). The solutions we examined span all stages of the patient pathway and display different degrees of business model autonomy, yet they all have one feature in common: Patient outcome, not products, is at the heart of the value proposition for customers. The next logical step, for those that heaven done so already, is to split patient-centric service offers from the drug and device business and develop them in a separate business unit. Pfizer Health Solutions is a case in point, as is Johnson Johnson Innovation. The fact that independent value-based healthcare services have started mainly in the area of treatment and monitoring (see figure 1) can be explained by the cost dynamics along the patient pathway: Conventional wisdom says prevention is the best medicine, but commercial reality is that it is the most poorly remunerated, at least in the public sector. At present, even private health insurers are more intent on capturing value at the cost- intensive end of the patient pathway than in prevention, where a business case for a patient-centric solution is much more difficult to make. That may be changing, however. Since the mid-sass, Dutch insurer Achaean has offered n interesting case study proving that integrated healthcare Figure 1 Most independent value-based healthcare services are in treatment and monitor Eng Business model autonomy Distribution and select examples of patient-centric solutions offerings Valuable services 8% Adjacent Proliferated 1% 3% 19% Pfizer care managers to coach patients with long-term conditions Philips interactive platform to monitor and support behavior change among chronically ill patients 12% 23% Roachs home urine tests to detect urinary tract infections 0% Innovators support program for patients being treated for wet age-related muscular generation prevention Diagnosis Treatment Monitoring Patient pathway Notes: The number in each box represents the percentage of offerings identified for each type of service and step of the patient pathway. In each row, a deeper color indicates a greater number of services. Source: A. T. Carney analysis of more than 100 services offered by pharmaceutical and medical technology firms 4 services can be a profitable way to effectively manage diseases-?and we expect the aging of the population, especially in Europe, to drive further adoption of patient-centric solutions. Where Do Patient-Centric Solutions Go From Here? Although the sheer number of services shows a rapidly evolving field, none of the models we analyzed has revolutionized healthcare delivery. A broad deployment of patient-centric solutions is still hampered by powerful barriers, both externally in the health marketplace and internally in the pharmaceutical and medical technology organizations. Among these barriers: misaligned incentives, distrust, and insufficiently developed capabilities (see sidebar: Barriers to Patient-Centric Solutions). Barriers to Patient-Centric Solutions A number of barriers, both external and internal, are standing in the way of widespread adoption of patient-centric healthcare solutions. External barriers Lack of collaboration and alignment. Healthcare is a complex world. Navigating interests from patient to provider to healthcare payer is not easy in the normal conduct of business, let alone when introducing innovative models. Health insurance companies in Germany, for example, tried to introduce disease management programs that largely failed because resident physicians, while essential to the programs implementation, were not involved in their design. 2 No consensus on evidence. In the long run, economic health outcomes of patient-centric arrive models will need to be proved in the same way that drug effectiveness is shown in a Phase Ill randomized clinical trial. But quantifying savings in the real world is more difficult, and studies on health economic outcomes are less amenable to scale than clinical studies: Patients and disease biology across the world are similar, but healthcare systems and their funding rules are not. On high product margins and do not want them to interfere with patient interactions. Misleading incentives for parts of the healthcare system. A shorter focus, combined with tight regulatory control over operations ND balance sheets, severely limits health insurance companies will to innovate. Meanwhile, paternalistic service models are only attractive for new entrants if they yield revenue that reflects the value contributed-?revenue that depends on payers willingness to fund these services. Internal barriers Insufficient patient targeting. Because the value proposition of patient-centric service models relies on a clear health outcome for the patients enrolled, it is crucial to not only target the right patients but also get them actively involved. Distrust resulting in a lack of access to patients. In most countries, pharmaceutical and deiced technology companies are restricted from directly marketing to patients or even pharmacies. Physicians-?and many patients-?still perceive pharmaceutical firms as focused Lack of new capability profiles. Pharmaceutical companies have excellent clinical understanding, but they lack experience in service deployment and design. Managing regular customer communication as part of a distinctive value proposition and not as a duty to drug safety is also new to an organization that is accustomed to molecules as value drivers. For technology companies, deploying local services and managing customer and maintenance immunization is easier, but they lack an understanding of the healthcare systems reimburse resentment schemes. Insufficient understanding of service-based business models in product-based environments. Capability gaps can be overcome with a smart deployment of resources, but the lack of understanding about the features of a service-based versus a product-based business and revenue model is more difficult to overcome. Recent legislation in Germany has abolished incentives for disease management programs, effectively removing them from the agenda. 5 So far, these barriers have prevented greater adoption of patient-centric lotions-?in Europe, less than 0. 5 percent of the more than 70 million chronic patients participate in health service programs (see figure 2)-?and a growing business can only be established once successful innovators clear these barriers. Figure 2 Barriers are preventing the significant adoption of patient-centric services Degree of expectation versus actual population addressed in Europe Today Degree of expectation Over-promise Realistic purport entities Growth Late followers Population at risk (prevention) 70 million addressed Innovators Patients in innovative healthcare niches 0. 5 million Early adopters High-need chronic or ever patients Early majority Chronic patients at risk of developing severe conditions Market development Note: Patient numbers based on chronic diseases in Europe Sources: Gardner; A. T. Carney analysis Technology will speed up the game and force decisions. Data generation, collection, and handling will be faster and more accessible than ever before: ; Healthcare devices will become commoditized. Prices will come down for everything from basic X-ray machines at the point of care in rural emerging markets to home diagnostic equipment in supermarkets. Wireless communication will become standard, including machine-to- aching (MM) communication. The Internet of things will be a reality before the molecules screened in todays pharmaceutical laboratories have been launched. New tools and algorithms will generate insight from data that will direct the health services of the future, as exemplified by SAPs expected applications of its business data analysis tool, HANNA, in healthcare. Collectively, these trends will bring down the technological barriers to entry and create opportunities for new entrants and innovative start-ups to provide new solutions.

Pygmalion Social Class and Higgins Essay

Pygmalion Social Class and Higgins Essay Pygmalion: Social Class and Higgins Essay Pygmalion Professor Henry Higgins :Professor of phonetics, goes into the opposite direction from the rest of the society. The world hasn’t turned against him is because he is a kind man. He can be a bully. Eliza Doolittle -Her character becomes much more instrumental to fundamental after the ambassador’s party. When she decides to make a statement of her own dignity to Higgins, she becomes not a duchess but an independent girl. It makes Higgins sees Eliza differently as a creature worthy of his admiration. Colonial Pickering -A gentleman who is always considerate. He appears most of all to be a civilized foil to Higgins’ barefoot. When Higgins appears to teach Eliza pronunciation, it is Pickering’s thoughtful treatment towards Eliza that teaches her to respect herself. Alfred Doolittle -A dustman who seems free from fear in the society. He is merciless to offer selling Eliza to Higgins and get some money out of the circumstance. Through Higgins’ joking recommendation, he becomes a moral status. Mrs Higgins -the first and only character who qualms about the affair. She knows what will happen to Eliza. The strategies a character devises for getting what he or she wants. Compare the Class Systems and How They Promote Social Equality in the Play â€Å"Pygmalion† Upper class They stereotyped how the lower class lived and called them names such as â€Å"baggage† and â€Å"blackguard†. Shaw is very much a feminist by addressing Higgins and Colonel talking about women in Act 2. He mentions that the upper class are mean and not fair to others. In Shaw’s time of living, there were 3

Discussion 7 Essay Example | Topics and Well Written Essays - 250 words - 1

Discussion 7 - Essay Example The first woman wore solid-color blouses, the second woman was middle aged and wore sophisticated shoes and dress whereas the third woman was trying to be attractive and wore jumpers which were provocative in nature and appealing. The author says that she noticed a great stability in the dressing styles of men as there were no volatile standards in dressing and shoe wear. She said that when she thought about the reason for not noticing the men in the conference, she came to know the fact that men are not marked. There do not try to be extra prominent anywhere. She says that she is there is no such thing as biological differences when it comes to the classification of genders rather it the â€Å"marking† factor which makes us man or woman. She gives the reference of the famous author Fasold who said the terms which are used to differentiate between men and women on the biological levels surfaced in the 19th century as the sex-indefinite pronouns. She says that being â€Å"marked† is the necessity for woman as they cannot survive in the cooperate world whereas men can work being

Meaningful use Essay Example | Topics and Well Written Essays - 1000 words

Meaningful use - Essay Example Meaningful use refers to the application of certified EHR technology in attaining specific healthcare objectives. Meaningful use is centered along the roles of healthcares professions and hospitals with respect to the adoption and implementation of EHR technology in their respective practice (CDC, 2013). This claim can be justified by the guidelines of the EHR incentive program, which requires medical professionals and hospitals to demonstrate that their chosen certified EHR has met specific health outcomes priorities. The concept of meaningful use is based on a number of vital health outcome priorities which include but not limited to improved population and public health; enhanced privacy and security of patient medical information; superior quality, efficiency, safety and minimized health disparities; enhanced care coordination; and increased engagement of patients and their families in the care (â€Å"Policymaking, Regulation†, 2012). This means that eligible medical profe ssions and hospitals must ensure that their certified EHR meets the above results before they get CMS inventive payment. The healthcare outcomes will be used as the criteria for establishing effective use of the deployed health IT tools by healthcare providers. According to the CMS incentive program eligible medical professionals, hospitals and critical access hospitals (CAHs) will receive up to $44,000 over 5 years and up to $63,750 over 6 years through the Medicare and Medicaid EHR incentive program respectively (CDC, 2013). It is noteworthy that CMS inventive program is voluntary, but negative consequences especially financial ones have been put in place for medical providers who fail to join the program by 2015. The concept of Meaningful Use was first introduced during the Obama administration though enactment and final signing of the American Recovery and Reinvestment Act (ARRA) of 2009 into law (Flanders, 2010). The ARRA through a number of measures particularly the "Health In formation Technology for Economic and Clinical Health (HITECH) Act" has witnessed improved national healthcare IT infrastructure. The HITECH proposed the concept of meaningful use of the EHR through the country’s healthcare delivery system as a vital national goals and it remains to be the critical focus for legislative, financial and ethical concern for hospitals and professional in the healthcare sector (â€Å"Policymaking, Regulation†, 2012). The initiative for automating medical records is facilitated by the Office of the National Coordinator for Health IT (ONC) in conjunction with Centers for Medicare & Medicaid Services (CMS) after the current administration realized that IT infrastructure is impetus for addressing longstanding healthcare challenges which range from escalating healthcare costs, low quality and safety, as well as high wastage (CDC, 2013). Meaningful Use has been divided into phases in order to encourage gradual widespread EHR adoption and implemen tation universally besides relieving excessive burden on medical care providers. The first phase which covers 2011 involves aspects of data capture and sharing; the second face, which involves advanced clinical processes elements covers up to 2013 while the final phase involves